Stocks
BioMarin Pharmaceutical (BMRN) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2022 | 2023 | LTM ? | ||||
| EBITDA, bln rub | ? | 48.0 | 165.7 | 159.5 | 262.0 | 308.0 | ||
| Changes by years, y/y, % | -921% | -100% | -4% | +64% | ||||
BioMarin Pharmaceutical. EBITDA US GAAP, bln rub
BioMarin Pharmaceutical. EBITDA US GAAP, changes, %
BioMarin Pharmaceutical. EBITDA US GAAP, sum by quarters, bln rub
BioMarin Pharmaceutical (BMRN) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 25 661 | 48.5 | 41.1 | 109.2 | 109.2 | 308.0 | |
| Changes by years, y/y, % | +92 952% | +76% | +287% | +26% | +26% | |||
| Changes by quarters, q/q, % | +31 122% | -100% | -15% | +166% | 0% | |||
